4 / 6
Page 11
December 09-10, 2019 | Barcelona, Spain
Volume 02
Journal of Immune Disorders & Therapy
J Immune Disord Ther, Volume 02
World Immunology 2019 & Cancer Summit 2019
December 09-10, 2019
9
th
WORLD CONGRESS ON
IMMUNOLOGY AND CANCER
Intracellular calcium regulation in neuroblastoma chemotherapy
C
alcium signaling controls various process within the cell. Calcium (Ca2+), it is an
important second messenger whose concentration is tightly controlled. A dysregulated
calcium concentration is implicated in many pathological conditions including cancer. Here
it modulates proliferation, evasion of apoptosis, invasion, migration, angiogenesis.
The presentation gives an overview of channels and pumps involved in the regulation of intra
cellular calcium [Ca2+]
i
. We present the effects of two anticancer drugs cisplatin (CDDP)
and arsenic trioxide (AS
2
O
3
) in calcium dynamics of Neuro Blastoma (NB) chemotherapy.
We show that anticancer drugs increase [Ca2+]
i
by different mechanisms in a time and
concentration dependent manner. Assay for apoptosis demonstrated proportional increase in
apoptotic cell with the increase in [Ca2+]
i
in NB cells exposed to CDDP. Quantification of
protein expression (confocal microscopy) of IP3R1, IP3R3, RYR1, RYR3 or S100A6 following exposure to either 1 μM 72h
CDDP showed upregulated protein expression. Development of resistance to chemotherapy is another problem developed in the
course of cancer treatment. Our data show that calcium regulating protein expression varies between the wild type and resistant
NB cell lines. Such as S100A6 protein had an altered cell distribution in resistant cell compared to the wild type. Microarray
mRNAanalysis reveals the calcium-dependent activation of signaling pathways involved in p53 signaling, cell cycle control and
RNAtransport.Also, the difference in mRNAmicro array profile was evident between the wild type and the resistant cell line. In
conclusion, pharmacological modulation of the [Ca2+]
i
response to cytotoxic drugs induced apoptosis in NB cells. Manipulating
the [Ca2+]
i
signaling in anticancer chemotherapy opens the chances for more studies in combinatory therapy using [Ca2+]
i
regulating drugs (blockers/ promoters).
Biography
Dietrich Büsselberg is Professor of Physiology and Biophysics at Weill Cornell Medicine in Qatar and Assistant Dean for Premedical Student
Affairs. Prior to coming to WCM-Q, he served as Professor of Physiology and Neuroscience at Texas Tech University, Health Science Center,
Paul L. Foster School of Medicine. Dr. Büsselberg holds a State Exam for Teaching from the University of Hannover, Germany (1981) a B.S
and M.S. from University of Hohenheim, Stuttgart, Germany (1987) and a Ph.D. from the University of Hohenheim (Germany), Institute of
Zoology in collaboration with the University of Albany (U.S.), School of Public Health (1989).
dib2015@qatar-med.cornell.eduDietrich Büsselberg
Weill Cornell Medicine, Qatar
Figure 1: Calcium regulating protein expression in
wildtype and neuroblastoma exposed to cisplatin